This enables the formation of boronate ester that is stable at physiological pH, maintaining BTZ in its inactive form, while dissociating under acidic conditions of tumor microenvironment (extracellular environment, late endosome, or lysosome). This evidence concerns the gene CASC3 and neoplasm.